Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Jul. 31, 2015

Quarterly Financial Data (Unaudited) [Abstract]

Summary of quarterly financial information

The following table provides the Company’s quarterly information as presented in the Form 10-Q (dollars in thousands except share and per share data):

Quarters ended:	July 31, 2015*		April 30, 2015*		January 31, 2015*		October 31, 2014
Net sales	$	20,809	$	19,375	$	18,189	$	16,646
Gross profit		11,258		10,105		9,584		9,270
Operating income		1,966		1,769		1,198		1,157
Net income		1,529		1,229		952		768
Earnings per share - basic	$	0.06	$	0.05	$	0.04	$	0.03
Earnings per share - diluted	$	0.06	$	0.05	$	0.04	$	0.03
Basic weighted average common shares outstanding		25,372,653		25,371,764		25,364,574		25,339,983
Diluted weighted average common shares outstanding		25,505,648		25,476,336		25,424,835		25,390,181

Quarters ended:	July 31, 2014**		April 30, 2014		January 31, 2014			October 31, 2013
Net sales	$	18,008	$	16,135	$	15,096		$	15,530
Gross profit		9,995		8,912		8,398			8,924
Operating income		2,156		1,411		(377	)		1,391
Net income		1,410		943		(225	)		935
Earnings per share – basic	$	0.06	$	0.04	$	(0.01	)	$	0.04
Earnings per share – diluted	$	0.06	$	0.04	$	(0.01	)	$	0.04
Basic weighted average common shares outstanding		25,352,326		25,331,925		25,309,641			25,294,020
Diluted weighted average common shares outstanding		25,400,341		25,392,782		25,309,641			25,389,940

*           The results of Sterimedix are reflected in our results of operations since December 10, 2014, the date of acquisition and reflect the following:

Net sales	$	2,342	$	2,266	$	1,066
Net income	$	517	$	320	$	14

**        The results of the private OEM Company have been reflected in our results of operations since May 3, 2014, the date of the acquisition.